Valiant Organics reports strong H1-FY26 performance, recovery from prior year loss

Valiant Organics Limited recorded an operational revenue of INR 3,617 million for H1-FY26, a 10.2% increase compared to H1-FY25. The company’s EBITDA surged to INR 459 million, with EBITDA margins expanding to 12.69% from 5.55% in the prior year. This strong performance was driven by better realizations and steady demand, supported by improved raw-material efficiency and product mix.

For Q2-FY26, the company reported operational revenue of INR 1,573 million and an EBITDA of INR 212 million, resulting in EBITDA margins of 13.48%. Profit after tax (PAT) for H1-FY26 stood at INR 139 million, a notable recovery from a loss of INR 131 million in H1-FY25. PAT margins for H1-FY26 reached 3.84%.

The company's key chemistries include Hydrogenation (50% of H1-FY26 revenue share), Ammonolysis (25%), and Chlorination (20%). Pharmaceuticals (13%), Dyes & Pigments (52%), and Agrochemicals (25%) represent the primary end-user industries for Valiant Organics. The company attributes its positive results to disciplined cost control, improved raw-material management, and reduced finance expenses.